TrialCancer2016

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.

Sameh Gaballa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.